Stengone Carmine N.
CEO and President
Sale 10b5-1
- Shares
- 2,500
- Price
- $16.46
- Value
- $41,142
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•33 filings
CTNM
Contineum Therapeutics, Inc.
Net sales of $81.2K over the last 3 months
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$81,171
0 buyers · 1 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$1,858,331
3 distinct insiders
Highlighted alerts
0
31 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get CTNM insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
CTNM overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
84
Raw transactions
Everything returned by the filing
31
Voluntary view
P/S trades after deterministic checks
53
Administrative noise
Stored, never alerted
72
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 2,500
- Price
- $1.01
- Footnotes
- 3
These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.29 to $16.59, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Options granted under the Issuer's 2012 Equity Incentive Plan (the "Plan"). The option is fully vested.
Raspberry interpretation
Informational — no alert
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Stengone Carmine N.
CEO and President
Sale 10b5-1
- Shares
- 2,500
- Price
- $16.01
- Value
- $40,029
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 25
- Price
- $16.00
- Value
- $400.00
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 1,015
- Price
- $16.00
- Value
- $16,240
Stengone Carmine N.
CEO and President
Sale 10b5-1
- Shares
- 2,500
- Price
- $16.00
- Value
- $40,000
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 2,501
- Price
- $16.24
- Value
- $40,608
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 5,852
- Price
- $15.67
- Value
- $91,682
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 28,826
- Price
- $16.04
- Value
- $462,288
Watkins Tim
CMO & Head of Development
Sale 10b5-1
- Shares
- 10,833
- Price
- $16.02
- Value
- $173,590
Stengone Carmine N.
CEO and President
Sale 10b5-1
- Shares
- 10,000
- Price
- $16.01
- Value
- $160,080
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 4,170
- Price
- $13.16
- Value
- $54,862
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 300
- Price
- $13.84
- Value
- $4,152
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 3,870
- Price
- $13.06
- Value
- $50,542
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 4,170
- Price
- $13.43
- Value
- $56,014
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 4,170
- Price
- $15.01
- Value
- $62,585
Watkins Tim
CMO & Head of Development
Sale 10b5-1
- Shares
- 3,611
- Price
- $15.02
- Value
- $54,220
Stengone Carmine N.
CEO and President
Sale 10b5-1
- Shares
- 2,700
- Price
- $16.02
- Value
- $43,242
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 3,824
- Price
- $16.01
- Value
- $61,228
Stengone Carmine N.
CEO and President
Sale 10b5-1
- Shares
- 4,400
- Price
- $16.02
- Value
- $70,486
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 4,300
- Price
- $16.03
- Value
- $68,936
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 100
- Price
- $16.00
- Value
- $1,600
Stengone Carmine N.
CEO and President
Sale 10b5-1
- Shares
- 400
- Price
- $16.00
- Value
- $6,400
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 400
- Price
- $16.00
- Value
- $6,400
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 1,170
- Price
- $15.25
- Value
- $17,837
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 3,000
- Price
- $14.82
- Value
- $44,469
Watkins Tim
CMO & Head of Development
Sale 10b5-1
- Shares
- 811
- Price
- $14.48
- Value
- $11,747
Watkins Tim
CMO & Head of Development
Sale 10b5-1
- Shares
- 2,800
- Price
- $14.09
- Value
- $39,441
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 500
- Price
- $11.13
- Value
- $5,565
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 3,670
- Price
- $10.35
- Value
- $37,978
Watkins Tim
CMO & Head of Development
Sale 10b5-1
- Shares
- 3,611
- Price
- $12.06
- Value
- $43,558
Lorrain Daniel S.
Chief Scientific Officer
Sale 10b5-1
- Shares
- 4,170
- Price
- $12.23
- Value
- $51,009
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 08, 2026 | Stengone Carmine N. CEO and President | Sale | 2,500 | $16.46 | $41,142 | |
| Aug 03, 2026 | Stengone Carmine N. CEO and President | Sale | 2,500 | $16.01 | $40,029 | |
| Jul 09, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 25 | $16.00 | $400.00 | |
| Jul 08, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 1,015 | $16.00 | $16,240 | |
| Jul 08, 2026 | Stengone Carmine N. CEO and President | Sale | 2,500 | $16.00 | $40,000 | |
| Jul 01, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 2,501 | $16.24 | $40,608 | |
| Jul 01, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 5,852 | $15.67 | $91,682 | |
| Jun 30, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 28,826 | $16.04 | $462,288 | |
| Jun 30, 2026 | Watkins Tim CMO & Head of Development | Sale | 10,833 | $16.02 | $173,590 | |
| Jun 30, 2026 | Stengone Carmine N. CEO and President | Sale | 10,000 | $16.01 | $160,080 | |
| Jun 01, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 4,170 | $13.16 | $54,862 | |
| May 01, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 300 | $13.84 | $4,152 | |
| May 01, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 3,870 | $13.06 | $50,542 | |
| Apr 06, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 4,170 | $13.43 | $56,014 | |
| Mar 02, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 4,170 | $15.01 | $62,585 | |
| Mar 02, 2026 | Watkins Tim CMO & Head of Development | Sale | 3,611 | $15.02 | $54,220 | |
| Feb 25, 2026 | Stengone Carmine N. CEO and President | Sale | 2,700 | $16.02 | $43,242 | |
| Feb 25, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 3,824 | $16.01 | $61,228 | |
| Feb 24, 2026 | Stengone Carmine N. CEO and President | Sale | 4,400 | $16.02 | $70,486 | |
| Feb 24, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 4,300 | $16.03 | $68,936 | |
| Feb 19, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 100 | $16.00 | $1,600 | |
| Feb 11, 2026 | Stengone Carmine N. CEO and President | Sale | 400 | $16.00 | $6,400 | |
| Feb 11, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 400 | $16.00 | $6,400 | |
| Feb 03, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 1,170 | $15.25 | $17,837 | |
| Feb 03, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 3,000 | $14.82 | $44,469 | |
| Jan 28, 2026 | Watkins Tim CMO & Head of Development | Sale | 811 | $14.48 | $11,747 | |
| Jan 28, 2026 | Watkins Tim CMO & Head of Development | Sale | 2,800 | $14.09 | $39,441 | |
| Jan 05, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 500 | $11.13 | $5,565 | |
| Jan 05, 2026 | Lorrain Daniel S. Chief Scientific Officer | Sale | 3,670 | $10.35 | $37,978 | |
| Dec 29, 2025 | Watkins Tim CMO & Head of Development | Sale | 3,611 | $12.06 | $43,558 | |
| Dec 23, 2025 | Lorrain Daniel S. Chief Scientific Officer | Sale | 4,170 | $12.23 | $51,009 |